Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2000
Linkage exclusion in French families with probable Parkinson' s disease
M Farrer, T Destée, E Becquet, et al.
Neurology
|
May 30, 2002
Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
E K Green, J M Harris, H Lemmon, et al.
Neuroscience Letters
|
August 3, 1999
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease
S Lincoln, R Crook, M C Chartier-Harlin, et al.
Acta Neuropathologica
|
January 1, 1996
Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes
L Buée, J Pérez-Tur, B Leveugle, et al.
Neuroscience Letters
|
July 31, 2002
The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease
C L Lendon, U Thaker, J M Harris, et al.
Neuroscience Letters
|
December 31, 2003
A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease
J Tian, J Shi, K Bailey, et al.
Neuroscience Letters
|
February 23, 1999
No pathogenic mutations in the persyn gene in Parkinson's disease
S Lincoln, K Gwinn-Hardy, J Goudreau, et al.
Journal of Neurochemistry
|
June 1, 1999
A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue
N Sato, O Hori, A Yamaguchi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 21, 2004
A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease
A Hayes, E K Green, A Pritchard, et al.
Human Molecular Genetics
|
December 10, 1999
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study
J C Lambert, T Brousseau, V Defosse, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2000
Linkage exclusion in French families with probable Parkinson' s disease
M Farrer, T Destée, E Becquet, et al.
Neurology
|
May 30, 2002
Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
E K Green, J M Harris, H Lemmon, et al.
Neuroscience Letters
|
August 3, 1999
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease
S Lincoln, R Crook, M C Chartier-Harlin, et al.
Acta Neuropathologica
|
January 1, 1996
Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes
L Buée, J Pérez-Tur, B Leveugle, et al.
Neuroscience Letters
|
July 31, 2002
The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease
C L Lendon, U Thaker, J M Harris, et al.
Neuroscience Letters
|
December 31, 2003
A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease
J Tian, J Shi, K Bailey, et al.
Neuroscience Letters
|
February 23, 1999
No pathogenic mutations in the persyn gene in Parkinson's disease
S Lincoln, K Gwinn-Hardy, J Goudreau, et al.
Journal of Neurochemistry
|
June 1, 1999
A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue
N Sato, O Hori, A Yamaguchi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 21, 2004
A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease
A Hayes, E K Green, A Pritchard, et al.
Human Molecular Genetics
|
December 10, 1999
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study
J C Lambert, T Brousseau, V Defosse, et al.
Page
of 7